載入...
ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer
BACKGROUND: In colorectal cancer (CRC), BRAF mutations influence tumour progression. In mismatch repair-deficient (dMMR) tumours, BRAF mutations are associated with a good prognosis, whereas in MMR-competent tumours, they are detrimental. The differential expression of the downstream MAPK pathway me...
Na minha lista:
| 發表在: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6070918/ https://ncbi.nlm.nih.gov/pubmed/29988110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0174-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|